Active Recombinant Human EGFR, His&Avi-tagged, Biotinylated
Cat.No. : | EGFR-285H |
Product Overview : | Recombinant Human EGFR(Leu 25 - Ser 645), fused with His&Avi-tag at C-terminal, Biotinylated, was produced in human 293 cells (HEK293). |
- Specification
- Gene Information
- Related Products
Source : | HEK293 |
Species : | Human |
Tag : | His&Avi |
Predicted N Terminal : | Leu 25 |
Form : | Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally Mannitol or Trehalose are added as protectants before lyophilization. |
Bio-activity : | Measured by its binding ability in a functional ELISA. Immobilized CetuxiMab at 2 μg/mL (100 μL/well) can bind Biotinylated rh EGFR, Avi Tagged with a linear range of 0.002-0.2 μg/mL. |
Molecular Mass : | Have a calculated MW of 71.2 kDa. The predicted N-terminus is Leu 25. DTT-reduced Protein migrates as 110-115 kDa in SDS-PAGE due to glycosylation. |
Endotoxin : | Less than 1.0 EU per μg of the Biotinylated rh EGFR /ErbB1, His.Avi Tag by the LAL method. |
Purity : | >95% as determined by SDS-PAGE. |
Applications : | By co-expression with biotin ligase (BirA enzyme), Biotinylated Human EGFR /ErbB1, His.Avi Tag was biotinylated in vivo for detection in ELISA, dot blot or western blot using streptavidin or avidin-conjugated probes. |
Storage : | Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4°C); After reconstitution under sterile conditions for 3 months (-70°C). |
Gene Name : | EGFR epidermal growth factor receptor [ Homo sapiens ] |
Official Symbol : | EGFR |
Synonyms : | ERBB; HER1; mENA; ERBB1; PIG61; NISBD2; epidermal growth factor receptor; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; cell growth inhibiting protein 40; cell proliferation-inducing protein 61; erb-b2 receptor tyrosine kinase 1; proto-oncogene c-ErbB-1; receptor tyrosine-protein kinase erbB-1 |
Gene ID : | 1956 |
mRNA Refseq : | NM_005228 |
Protein Refseq : | NP_005219 |
MIM : | 131550 |
UniProt ID : | P00533 |
Chromosome Location : | 7p12 |
Pathway : | AGE/RAGE pathway, organism-specific biosystem; Adherens junction, organism-specific biosystem; Arf6 signaling events, organism-specific biosystem |
Function : | ATP binding; MAP kinase kinase kinase activity; chromatin binding |
Products Types
◆ Recombinant Protein | ||
EGFR-213H | Recombinant Human EGFR Protein, Strep-tagged | +Inquiry |
EGFR-077H | Recombinant Human EGFR Protein, DYKDDDDK-tagged | +Inquiry |
EGFR-0974H | Recombinant Human EGFR Protein (L25-A1210), eGFP, Strep II, 10×His tagged | +Inquiry |
EGFR-26H | Recombinant Human EGFR (P772_H773insNP) Mutant Protein, GST-tagged | +Inquiry |
EGFR-03H | Recombinant Human EGFR Protein, GST-tagged | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionIt is associated with biological processes in human embryonic development and tissue regeneration.
EGFR inhibits adverse drug reactions such as rash, inflammation, and diarrhea during drug treatment.
The role of EGFR in tumor treatment is to act as a molecular marker and can be used as a prognostic indicator and monitor tumor progression; at the same time, EGFR mutations can also be targeted for targeted therapy.
EGFR gene mutation detection generally uses PCR, fluorescence in situ hybridization, and direct sequencing.
The combination of EGFR inhibitors with chemotherapy drugs, radiotherapy, immunotherapy, etc. can increase the efficacy of treatment and reduce the occurrence of adverse reactions.
EGFR mutations can have a significant impact on the efficacy of targeted therapies, and patients with mutations have higher response rates.
Customer Reviews (3)
Write a reviewThe powerful biological activity of EGFR combined with its high purity makes the experimental results highly reproducible, which is of great significance in the field of scientific research.
Due to the short half-life and high clearance characteristics of EGFR, they can better adapt to the needs of clinical treatment and provide more treatment options for patients.
The production process of EGFR uses advanced biotechnology, which makes the production process more efficient and environmentally friendly, and reduces the consumption of human and material resources.
Ask a Question for All EGFR Products
Required fields are marked with *
My Review for All EGFR Products
Required fields are marked with *
Inquiry Basket